Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Estimates of Cross-Border Menthol Cigarette Sales Following the Comprehensive Tobacco Flavor Ban in Massachusetts

View ORCID ProfileJacob James Rich
doi: https://doi.org/10.1101/2022.04.24.22274236
Jacob James Rich
1Department of Quantitative and Population Health Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio
2Drug Policy Project, Reason Foundation, Los Angeles, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jacob James Rich
  • For correspondence: jacob.j.rich@case.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

On June 1, 2020, Massachusetts became the first state in the US to ban all flavored tobacco product sales, including menthol cigarettes. Recent research has estimated the reduction in cigarette sales in Massachusetts following the comprehensive tobacco flavor ban, but noted that missing data on border states was a major limitation of the findings. This letter replicates the procedures of Asare et al. with 1540 state-months and then adds Asare et al.’s missing states with 2420 total observations for the period January 2017 to July 2021. The replication confirms Asare et al.’s adjusted estimate for the reduction in menthol cigarettes, which falls within their 95% confidence interval. However, assigning Massachusetts and its bordering states as a single treatment group leads to an increase of 191.95 (95% CI, 96.82 to 287.09) total cigarette packs sold per 1000 people in the six-state region. In the 12-month period following the comprehensive flavor ban in Massachusetts, the state sold 29.96 million fewer cigarette packs compared to the prior period. However, a total of 33.36 million additional cigarette packs were sold during the same post-ban period in the counties that bordered Massachusetts. Given decreasing rates of smoking in all five bordering states between 2019 and 2020, the increase in border-state cigarette sales following the comprehensive flavor ban should be interpreted as a lower-bound estimate for cigarettes that were ultimately consumed in Massachusetts.

Methods

Using monthly MSAi retailer to wholesaler cigarette shipment data, Asare et al.’s difference-in-differences estimates are replicated to measure changes in state-level sales of menthol, nonflavored, and total cigarette packs. These estimates are then compared to an identical specification that adds Washington, DC and the 15 missing states without tobacco flavor bans during the same period. Massachusetts and its bordering states are then evaluated as treatment groups.

Descriptive statistics for the variables of interest matched the means in the original analysis, minus those for cigarette prices, household income, and COVID-19 case rates (Supplement).[2] There are also outcome differences because the Nielsen Retail Scanner Data measuring cigarette sales in the original letter only represent approximately 30% of all US mass merchandiser sales volume.[3] In contrast, the MSAi data represent all cigarette distribution in the US. In order to match Asare et al.’s estimates, survey weights were removed from most of the IPUMS-CPS data.[4] All means that could not be matched were then verified by reports from the data-collecting agencies.

Results

The procedures of Asare et al. are replicated with 1540 state-months and then expanded with 2420 total observations for the period January 2017 to July 2021 (Supplement), with nondivergent trends in cigarette sales before treatment. After the prohibition, the replication confirms Asare et al.’s adjusted estimate for menthol cigarettes, which falls within their 95% confidence interval (Table 1). The complete model then estimates that the monthly sales of cigarette packs per 1000 people in Massachusetts decreased for menthol 292.66 (95% CI, -557.17 to -28.15) and increased for nonflavored 224.16 (95% CI, -144.30 to 592.64), resulting in a total reduction of 68.49 (95% CI, -608.36 to 471.37). However, assigning the border states as a single treatment group then leads to an increase of 80.57 (95% CI, 38.81 to 122.34) menthol and 119.88 (95% CI, 50.44 to 189.32) nonmenthol cigarette packs sold per 1000 people in the bordering states. Finally, assigning Massachusetts and its bordering states as a single treatment group leads to an increase of 191.95 (95% CI, 96.82 to 287.09) total cigarette packs sold per 1000 people in the six-state region.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 1. Difference-in-Differences Estimates for Cigarettes Sold per 1000 Population

In the 12-month period following the comprehensive flavor ban in Massachusetts, the state sold 29.96 million fewer cigarette packs compared to the prior period. However, a total of 33.36 million additional cigarette packs were sold during the same post-ban period in the counties that bordered Massachusetts (Figure 1). Considering the change in sales for the entire six-state region, there was a net increase of 7.21 million additional cigarette packs sold following the Massachusetts comprehensive flavor ban, a 1.27% increase from the prior 12-month period.

Figure 1.
  • Download figure
  • Open in new tab
Figure 1. Percent Change in Total Cigarette Pack Sales from Previous Year

Note: Percentage change references the same month in the previous year.

Discussion

State-level prohibitions on flavored tobacco sales are far less effective when bordering states and counties provide access to prohibited products. Additionally, tobacco flavor bans may lead to net increases in tobacco sales when outside localities charge lower excise taxes. Given decreasing rates of smoking in all five bordering states between 2019 and 2020,[5] the increase in border-state cigarette sales following the comprehensive flavor ban should be interpreted as a lower-bound estimate for cigarettes that were ultimately consumed in Massachusetts.

Data Availability

All predictor variables in the present work are available in the supplements. Most of the outcome data will be released by the CDC at a later date.

References

  1. 1.
    S. Asare, A. Majmundar, J. Westmaas, P. Bandi, Z. Xue, A. Jemal and N. Nargis, “Association of Cigarette Sales With Comprehensive Menthol Flavor Ban in Massachusetts,” JAMA Intern Med, vol. doi:10.1001/jamainternmed.2021.7333, January 04, 2022.
    OpenUrlCrossRef
  2. 2.↵
    CDC Case Task Force, “United States COVID-19 Cases and Deaths by State over Time,” Centers for Disease Control and Prevention, Atlanta, GA, April 23, 2022.
  3. 3.↵
    University of Chicago Kilts Center for Marketing, “NIELSEN AND NIELSENIQ MARKETING DATA,” 2022. [Online]. Available: https://www.chicagobooth.edu/research/kilts/datasets/nielsenIQ-nielsen. [Accessed 04 02 2022].
  4. 4.↵
    S. Flood, M. King, R. Rodgers, S. Ruggles, J. R. Warren and M. Westberry, “Integrated Public Use Microdata Series, Current Population Survey: Version 9.0 [dataset],” Minneapolis, MN, 2022.
  5. 5.↵
    U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, “State Data Tables and Reports From the 2019-2020 NSDUH,” Center for Behavioral Health Statistics and Quality, Rockville, MD, 2021.
Back to top
PreviousNext
Posted April 27, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Estimates of Cross-Border Menthol Cigarette Sales Following the Comprehensive Tobacco Flavor Ban in Massachusetts
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Estimates of Cross-Border Menthol Cigarette Sales Following the Comprehensive Tobacco Flavor Ban in Massachusetts
Jacob James Rich
medRxiv 2022.04.24.22274236; doi: https://doi.org/10.1101/2022.04.24.22274236
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Estimates of Cross-Border Menthol Cigarette Sales Following the Comprehensive Tobacco Flavor Ban in Massachusetts
Jacob James Rich
medRxiv 2022.04.24.22274236; doi: https://doi.org/10.1101/2022.04.24.22274236

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Health Policy
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1099)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (502)
  • Epidemiology (9778)
  • Forensic Medicine (5)
  • Gastroenterology (481)
  • Genetic and Genomic Medicine (2314)
  • Geriatric Medicine (223)
  • Health Economics (462)
  • Health Informatics (1563)
  • Health Policy (737)
  • Health Systems and Quality Improvement (605)
  • Hematology (238)
  • HIV/AIDS (505)
  • Infectious Diseases (except HIV/AIDS) (11653)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (238)
  • Medical Ethics (67)
  • Nephrology (258)
  • Neurology (2146)
  • Nursing (134)
  • Nutrition (338)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (518)
  • Oncology (1183)
  • Ophthalmology (365)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (147)
  • Palliative Medicine (50)
  • Pathology (312)
  • Pediatrics (697)
  • Pharmacology and Therapeutics (301)
  • Primary Care Research (267)
  • Psychiatry and Clinical Psychology (2186)
  • Public and Global Health (4668)
  • Radiology and Imaging (781)
  • Rehabilitation Medicine and Physical Therapy (457)
  • Respiratory Medicine (624)
  • Rheumatology (274)
  • Sexual and Reproductive Health (226)
  • Sports Medicine (210)
  • Surgery (252)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)